Discovery of antivirulence agents against methicillin-resistant staphylococcus aureus

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 8, 2013, Pages 3645-3652

  Khodaverdian, Varandt ^a,b   Pesho, Michelle ^a   Truitt, Barbara ^a   Bollinger, Lucy ^a,c   Patel, Parita ^a   Nithianantham, Stanley ^a,d   Yu, Guanping ^a,e   Delaney, Elizabeth ^a   Jankowsky, Eckhard ^a   Shoham, Menachem ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Case Western Reserve University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HEMOLYSIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; DIFLUNISAL; MODULIN ALPHA; NAPHTHALENE DERIVATIVE; RESPONSE REGULATOR AGRA; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANIMAL CELL; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; CONTROLLED STUDY; DRUG DEVELOPMENT; GROWTH INHIBITION; HUMAN; HUMAN CELL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION; VIRTUAL REALITY;

ANIMALS; BACTERIAL TOXINS; DIFLUNISAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; GENE EXPRESSION REGULATION, BACTERIAL; HEMOLYSIN PROTEINS; HEMOLYSIS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; NAPHTHALENES; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RABBITS; TRANSCRIPTION, GENETIC; VIRULENCE FACTORS;

EID: 84880323959     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00269-13     Document Type: Article

References (30)

1. Otto M. 2010. Basis of virulence in community-associated methicillinresistant Staphylococcus aureus. Annu. Rev. Microbiol. 64:143-162.
2. Lowy FD. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339: 520-532.
3. Rasmussen RV, Fowler VG, Jr, Skov R, Bruun NE. 2011. Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA. Future Microbiol. 6:43-56.
4. Pantosti A, Sanchini A, Monaco M. 2007. Mechanisms of antibiotic resistance in Staphylococcus aureus. Future Microbiol. 2:323-334.
5. Novick RP, Projan SJ, Kornblum J, Ross HF, Ji G, Kreiswirth B, Vandenesch F, Moghazeh S, Novick RP. 1995. The agr P2 operon: an autocatalytic sensory transduction system in Staphylococcus aureus. Mol. Gen. Genet. 248:446-458.
6. Koenig RL, Ray JL, Maleki SJ, Smeltzer MS, Hurlburt BK. 2004. Staphylococcus aureus AgrA binding to the RNAIII-agr regulatory region. J. Bacteriol. 186:7549-7555.
7. Lee SY, De La Torre A, Yan D, Kustu S, Nixon BT, Wemmer DE. 2003. Regulation of the transcriptional activator NtrC1: structural studies of the regulatory and AAA ATPase domains. Genes Dev. 17:2552-2563.
8. Arnold K, Bordoli L, Kopp J, Schwede T. 2006. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22:195-201.
9. Brünger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-Kunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS, Read RJ, Rice LM, Simonson T, Warren GL. 1998. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54:905-921.
10. Reynolds J, Wigneshweraraj S. 2011. Molecular insights into the control of transcription initiation at the Staphylococcus aureus agr operon. J. Mol. Biol. 412:862-881.
11. Sidote DJ, Barbieri CM, Wu T, Stock AM. 2008. Structure of the Staphylococcus aureus AgrA LytTR domain bound to DNA reveals a beta fold with an unusual mode of binding. Structure 16:727-735.
12. Leonard PG, Bezar IF, Sidote DJ, Stock AM. 2012. Identification of a hydrophobic cleft in the LytTR domain of AgrA as a locus for small molecule interactions that inhibit DNA binding. Biochemistry 51:10035-10043.
13. Inoshima I, Inoshima N, Wilke GA, Powers ME, Frank KM, Wang Y, Bubeck Wardenburg J. 2011. A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice. Nat. Med. 17:1310-1314.
14. Kobayashi SD, Malachowa N, Whitney AR, Braughton KR, Gardner DJ, Long D, Wardenburg JB, Schneewind O, Otto M, DeLeo FR. 2011. Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection. J. Infect. Dis. 204:937-941.
15. Kennedy AD, Bubeck Wardenburg J, Gardner DJ, Long D, Whitney AR, Braughton KR, Schneewind O, DeLeo FR. 2010. Targeting of alphahemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model. J. Infect. Dis. 202:1050-1058.
16. Wilke GA, Wardenburg JB. 2010. Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus alpha-hemolysin-mediated cellular injury. Proc. Natl. Acad. Sci. U. S. A. 107:13473-13478.
17. George EA, Novick RP, Muir TW. 2008. Cyclic peptide inhibitors of staphylococcal virulence prepared by Fmoc-based thiolactone peptide synthesis. J. Am. Chem. Soc. 130:4914-4924.
18. Rasko DA, Sperandio V. 2010. Anti-virulence strategies to combat bacteria-mediated disease. Nat. Rev. Drug Discov. 9:117-128.
19. Bubeck Wardenburg J, Schneewind O. 2008. Vaccine protection against Staphylococcus aureus pneumonia. J. Exp. Med. 205:287-294.
20. Ragle BE, Bubeck Wardenburg J. 2009. Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia. Infect. Immun. 77:2712-2718.
21. Ragle BE, Karginov VA, Bubeck Wardenburg J. 2010. Prevention and treatment of Staphylococcus aureus pneumonia with a beta-cyclodextrin derivative. Antimicrob. Agents Chemother. 54:298-304.
22. Loeffler B, Hussain M, Grundmeier M, Brueck M, Holzinger D, Varga G, Roth J, Kahl BC, Proctor RA, Peters G. 2010. Staphylococcus aureus Panton-Valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog. 6:e1000715. doi:10.1371/journal.ppat.1000715.
23. Bernheimer AW. 1965. Staphylococcal alpha toxin. Ann. N. Y. Acad. Sci. 128:112-123.
24. Park J, Jagasia R, Kaufmann GF, Mathison JC, Ruiz DI, Moss JA, Meijler MM, Ulevitch RJ, Janda KD. 2007. Infection control by antibody disruption of bacterial quorum sensing signaling. Chem. Biol. 14:1119-1127.
25. Queck SY, Jameson-Lee M, Villaruz AE, Bach TH, Khan BA, Sturdevant DE, Ricklefs SM, Li M, Otto M. 2008. RNAIII-independent target gene control by the agr quorum-sensing system: insight into the evolution of virulence regulation in Staphylococcus aureus. Mol. Cell 32:150-158.
26. Cheung AL, Ying P. 1994. Regulation of alpha-and beta-hemolysins by the sar locus of Staphylococcus aureus. J. Bacteriol. 176:580-585.
27. Saïd-Salim B, Dunman PM, McAleese FM, Macapagal D, Murphy E, McNamara PJ, Arvidson S, Foster TJ, Projan SJ, Kreiswirth BN. 2003. Global regulation of Staphylococcus aureus genes by Rot. J. Bacteriol. 185: 610-619.
28. Ohlsen K, Koller KP, Hacker J. 1997. Analysis of expression of the alpha-toxin gene (hla) of Staphylococcus aureus by using a chromosomally encoded hla::lacZ gene fusion. Infect. Immun. 65:3606-3614.
29. Even S, Charlier C, Nouaille S, Ben Zakour NL, Cretenet M, Cousin FJ, Gautier M, Cocaign-Bousquet M, Loubiere P, Le Loir Y. 2009. Staphylococcus aureus virulence expression is impaired by Lactococcus lactis in mixed cultures. Appl. Environ. Microbiol. 75:4459-4472.
30. Vaudaux P, Francois P, Bisognano C, Kelley WL, Lew DP, Schrenzel J, Proctor RA, McNamara PJ, Peters G, Von Eiff C. 2002. Increased expression of clumping factor and fibronectin-binding proteins by hemB mutants of Staphylococcus aureus expressing small colony variant phenotypes. Infect. Immun. 70:5428-5437.